• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

nanoparticles

An artists impression of influenza molecules The molecules are blue and have multicolored centers
Research

Tiba wins BARDA contract to develop RNAi flu therapeutics

The $749,999 contract will see Tiba Biotech build on previous work to develop new a RNAi-based therapeutic against the H1N1 strain of the swine flu.
Helen Floersh Jul 11, 2024 3:35pm
Digital rendering of a galaxy

Genentech spends $15M to rocket into GenEdit’s NanoGalaxy

Jan 23, 2024 7:00am
An artists concept of a nanoparticle shown in gold against a background with bright shades of purple and pink

Young livers may filter out nanodrugs, stifling their efficacy

Sep 25, 2023 5:30am
Graphic of employees walking out depicting layoffs

NexImmune halves team as cash forces focus on core capabilities

Sep 1, 2023 6:39am
Rainbow colored molecules of DNA

Takeda, Poseida see promising data for hemophilia A gene therapy

Dec 14, 2022 3:15pm
Concept of SARS-CoV-2 or COVID-19

Scientists explore 'mosaic', inhaled COVID-19 vaccine options

Jul 7, 2022 2:34pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings